Global Glucagon Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
According to APO Research, The global Glucagon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Glucagon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
Glucagon segment by Company
1. To analyze and research the global Glucagon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glucagon market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glucagon significant trends, drivers, influence factors in global and regions.
6. To analyze Glucagon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glucagon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucagon industry.
Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glucagon in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Glucagon market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Glucagon, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Glucagon, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Glucagon sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Glucagon market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Glucagon sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals and Xeris Pharmaceuticals, etc.
Glucagon segment by Company
- Novo Nordisk
- Eli Lilly
- Fresenius Kabi
- Torrent Labs
- Taj Pharmaceuticals
- Xeris Pharmaceuticals
- Inject Glucagon
- Nasal Glucagon
- Emergency Kits
- General Use
- Diagnostic & Motility
- Cardiogenic Shock
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Glucagon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Glucagon market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Glucagon significant trends, drivers, influence factors in global and regions.
6. To analyze Glucagon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glucagon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucagon industry.
Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Glucagon in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Sales Value (2019-2030)
1.2.2 Global Glucagon Sales Volume (2019-2030)
1.2.3 Global Glucagon Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 GLUCAGON MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 GLUCAGON MARKET BY COMPANY
3.1 Global Glucagon Company Revenue Ranking in 2023
3.2 Global Glucagon Revenue by Company (2019-2024)
3.3 Global Glucagon Sales Volume by Company (2019-2024)
3.4 Global Glucagon Average Price by Company (2019-2024)
3.5 Global Glucagon Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Glucagon Company Manufacturing Base & Headquarters
3.7 Global Glucagon Company, Product Type & Application
3.8 Global Glucagon Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Glucagon Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Glucagon Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 GLUCAGON MARKET BY TYPE
4.1 Glucagon Type Introduction
4.1.1 Inject Glucagon
4.1.2 Nasal Glucagon
4.2 Global Glucagon Sales Volume by Type
4.2.1 Global Glucagon Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Glucagon Sales Volume by Type (2019-2030)
4.2.3 Global Glucagon Sales Volume Share by Type (2019-2030)
4.3 Global Glucagon Sales Value by Type
4.3.1 Global Glucagon Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Glucagon Sales Value by Type (2019-2030)
4.3.3 Global Glucagon Sales Value Share by Type (2019-2030)
5 GLUCAGON MARKET BY APPLICATION
5.1 Glucagon Application Introduction
5.1.1 Emergency Kits
5.1.2 General Use
5.1.3 Diagnostic & Motility
5.1.4 Cardiogenic Shock
5.1.5 Others
5.2 Global Glucagon Sales Volume by Application
5.2.1 Global Glucagon Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Glucagon Sales Volume by Application (2019-2030)
5.2.3 Global Glucagon Sales Volume Share by Application (2019-2030)
5.3 Global Glucagon Sales Value by Application
5.3.1 Global Glucagon Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Glucagon Sales Value by Application (2019-2030)
5.3.3 Global Glucagon Sales Value Share by Application (2019-2030)
6 GLUCAGON MARKET BY REGION
6.1 Global Glucagon Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Glucagon Sales by Region (2019-2030)
6.2.1 Global Glucagon Sales by Region: 2019-2024
6.2.2 Global Glucagon Sales by Region (2025-2030)
6.3 Global Glucagon Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Glucagon Sales Value by Region (2019-2030)
6.4.1 Global Glucagon Sales Value by Region: 2019-2024
6.4.2 Global Glucagon Sales Value by Region (2025-2030)
6.5 Global Glucagon Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Glucagon Sales Value (2019-2030)
6.6.2 North America Glucagon Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Glucagon Sales Value (2019-2030)
6.7.2 Europe Glucagon Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Glucagon Sales Value (2019-2030)
6.8.2 Asia-Pacific Glucagon Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Glucagon Sales Value (2019-2030)
6.9.2 Latin America Glucagon Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Glucagon Sales Value (2019-2030)
6.10.2 Middle East & Africa Glucagon Sales Value Share by Country, 2023 VS 2030
7 GLUCAGON MARKET BY COUNTRY
7.1 Global Glucagon Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Glucagon Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Glucagon Sales by Country (2019-2030)
7.3.1 Global Glucagon Sales by Country (2019-2024)
7.3.2 Global Glucagon Sales by Country (2025-2030)
7.4 Global Glucagon Sales Value by Country (2019-2030)
7.4.1 Global Glucagon Sales Value by Country (2019-2024)
7.4.2 Global Glucagon Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.5.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.6.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.7.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.8.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.9.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.10.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.11.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.12.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.13.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.14.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.15.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.16.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.17.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.18.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.19.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.20.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.21.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.22.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.23.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Comapny Information
8.1.2 Novo Nordisk Business Overview
8.1.3 Novo Nordisk Glucagon Sales, Value and Gross Margin (2019-2024)
8.1.4 Novo Nordisk Glucagon Product Portfolio
8.1.5 Novo Nordisk Recent Developments
8.2 Eli Lilly
8.2.1 Eli Lilly Comapny Information
8.2.2 Eli Lilly Business Overview
8.2.3 Eli Lilly Glucagon Sales, Value and Gross Margin (2019-2024)
8.2.4 Eli Lilly Glucagon Product Portfolio
8.2.5 Eli Lilly Recent Developments
8.3 Fresenius Kabi
8.3.1 Fresenius Kabi Comapny Information
8.3.2 Fresenius Kabi Business Overview
8.3.3 Fresenius Kabi Glucagon Sales, Value and Gross Margin (2019-2024)
8.3.4 Fresenius Kabi Glucagon Product Portfolio
8.3.5 Fresenius Kabi Recent Developments
8.4 Torrent Labs
8.4.1 Torrent Labs Comapny Information
8.4.2 Torrent Labs Business Overview
8.4.3 Torrent Labs Glucagon Sales, Value and Gross Margin (2019-2024)
8.4.4 Torrent Labs Glucagon Product Portfolio
8.4.5 Torrent Labs Recent Developments
8.5 Taj Pharmaceuticals
8.5.1 Taj Pharmaceuticals Comapny Information
8.5.2 Taj Pharmaceuticals Business Overview
8.5.3 Taj Pharmaceuticals Glucagon Sales, Value and Gross Margin (2019-2024)
8.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
8.5.5 Taj Pharmaceuticals Recent Developments
8.6 Xeris Pharmaceuticals
8.6.1 Xeris Pharmaceuticals Comapny Information
8.6.2 Xeris Pharmaceuticals Business Overview
8.6.3 Xeris Pharmaceuticals Glucagon Sales, Value and Gross Margin (2019-2024)
8.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
8.6.5 Xeris Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Glucagon Value Chain Analysis
9.1.1 Glucagon Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Glucagon Sales Mode & Process
9.2 Glucagon Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Glucagon Distributors
9.2.3 Glucagon Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Sales Value (2019-2030)
1.2.2 Global Glucagon Sales Volume (2019-2030)
1.2.3 Global Glucagon Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 GLUCAGON MARKET DYNAMICS
2.1 Glucagon Industry Trends
2.2 Glucagon Industry Drivers
2.3 Glucagon Industry Opportunities and Challenges
2.4 Glucagon Industry Restraints
3 GLUCAGON MARKET BY COMPANY
3.1 Global Glucagon Company Revenue Ranking in 2023
3.2 Global Glucagon Revenue by Company (2019-2024)
3.3 Global Glucagon Sales Volume by Company (2019-2024)
3.4 Global Glucagon Average Price by Company (2019-2024)
3.5 Global Glucagon Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Glucagon Company Manufacturing Base & Headquarters
3.7 Global Glucagon Company, Product Type & Application
3.8 Global Glucagon Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Glucagon Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Glucagon Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 GLUCAGON MARKET BY TYPE
4.1 Glucagon Type Introduction
4.1.1 Inject Glucagon
4.1.2 Nasal Glucagon
4.2 Global Glucagon Sales Volume by Type
4.2.1 Global Glucagon Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Glucagon Sales Volume by Type (2019-2030)
4.2.3 Global Glucagon Sales Volume Share by Type (2019-2030)
4.3 Global Glucagon Sales Value by Type
4.3.1 Global Glucagon Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Glucagon Sales Value by Type (2019-2030)
4.3.3 Global Glucagon Sales Value Share by Type (2019-2030)
5 GLUCAGON MARKET BY APPLICATION
5.1 Glucagon Application Introduction
5.1.1 Emergency Kits
5.1.2 General Use
5.1.3 Diagnostic & Motility
5.1.4 Cardiogenic Shock
5.1.5 Others
5.2 Global Glucagon Sales Volume by Application
5.2.1 Global Glucagon Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Glucagon Sales Volume by Application (2019-2030)
5.2.3 Global Glucagon Sales Volume Share by Application (2019-2030)
5.3 Global Glucagon Sales Value by Application
5.3.1 Global Glucagon Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Glucagon Sales Value by Application (2019-2030)
5.3.3 Global Glucagon Sales Value Share by Application (2019-2030)
6 GLUCAGON MARKET BY REGION
6.1 Global Glucagon Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Glucagon Sales by Region (2019-2030)
6.2.1 Global Glucagon Sales by Region: 2019-2024
6.2.2 Global Glucagon Sales by Region (2025-2030)
6.3 Global Glucagon Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Glucagon Sales Value by Region (2019-2030)
6.4.1 Global Glucagon Sales Value by Region: 2019-2024
6.4.2 Global Glucagon Sales Value by Region (2025-2030)
6.5 Global Glucagon Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Glucagon Sales Value (2019-2030)
6.6.2 North America Glucagon Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Glucagon Sales Value (2019-2030)
6.7.2 Europe Glucagon Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Glucagon Sales Value (2019-2030)
6.8.2 Asia-Pacific Glucagon Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Glucagon Sales Value (2019-2030)
6.9.2 Latin America Glucagon Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Glucagon Sales Value (2019-2030)
6.10.2 Middle East & Africa Glucagon Sales Value Share by Country, 2023 VS 2030
7 GLUCAGON MARKET BY COUNTRY
7.1 Global Glucagon Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Glucagon Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Glucagon Sales by Country (2019-2030)
7.3.1 Global Glucagon Sales by Country (2019-2024)
7.3.2 Global Glucagon Sales by Country (2025-2030)
7.4 Global Glucagon Sales Value by Country (2019-2030)
7.4.1 Global Glucagon Sales Value by Country (2019-2024)
7.4.2 Global Glucagon Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.5.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.6.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.7.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.8.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.9.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.10.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.11.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.12.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.13.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.14.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.15.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.16.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.17.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.18.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.19.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.20.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.21.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.22.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Glucagon Sales Value Growth Rate (2019-2030)
7.23.2 Global Glucagon Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Glucagon Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Comapny Information
8.1.2 Novo Nordisk Business Overview
8.1.3 Novo Nordisk Glucagon Sales, Value and Gross Margin (2019-2024)
8.1.4 Novo Nordisk Glucagon Product Portfolio
8.1.5 Novo Nordisk Recent Developments
8.2 Eli Lilly
8.2.1 Eli Lilly Comapny Information
8.2.2 Eli Lilly Business Overview
8.2.3 Eli Lilly Glucagon Sales, Value and Gross Margin (2019-2024)
8.2.4 Eli Lilly Glucagon Product Portfolio
8.2.5 Eli Lilly Recent Developments
8.3 Fresenius Kabi
8.3.1 Fresenius Kabi Comapny Information
8.3.2 Fresenius Kabi Business Overview
8.3.3 Fresenius Kabi Glucagon Sales, Value and Gross Margin (2019-2024)
8.3.4 Fresenius Kabi Glucagon Product Portfolio
8.3.5 Fresenius Kabi Recent Developments
8.4 Torrent Labs
8.4.1 Torrent Labs Comapny Information
8.4.2 Torrent Labs Business Overview
8.4.3 Torrent Labs Glucagon Sales, Value and Gross Margin (2019-2024)
8.4.4 Torrent Labs Glucagon Product Portfolio
8.4.5 Torrent Labs Recent Developments
8.5 Taj Pharmaceuticals
8.5.1 Taj Pharmaceuticals Comapny Information
8.5.2 Taj Pharmaceuticals Business Overview
8.5.3 Taj Pharmaceuticals Glucagon Sales, Value and Gross Margin (2019-2024)
8.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
8.5.5 Taj Pharmaceuticals Recent Developments
8.6 Xeris Pharmaceuticals
8.6.1 Xeris Pharmaceuticals Comapny Information
8.6.2 Xeris Pharmaceuticals Business Overview
8.6.3 Xeris Pharmaceuticals Glucagon Sales, Value and Gross Margin (2019-2024)
8.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
8.6.5 Xeris Pharmaceuticals Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Glucagon Value Chain Analysis
9.1.1 Glucagon Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Glucagon Sales Mode & Process
9.2 Glucagon Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Glucagon Distributors
9.2.3 Glucagon Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
